MERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1b

Condition:   Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Interventions:   Drug: Combination of Lopinavir /Ritonavir and Interferon beta-1b;   Drug: Placebo Sponsor:   King Abdullah International Medical Research Center Not yet recruiting - verified July 2016

Source: ClinicalTrials.gov - June 20, 2016 Category: Research Source Type: clinical trials